- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/728 - Hyaluronic acid
Patent holdings for IPC class A61K 31/728
Total number of patents in this class: 2012
10-year publication summary
145
|
170
|
184
|
183
|
186
|
198
|
150
|
141
|
156
|
8
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Fidia Farmaceutici S.p.A. | 643 |
51 |
Seikagaku Corporation | 189 |
43 |
The Regents of the University of California | 19493 |
22 |
Allergan Industrie SAS | 93 |
22 |
Altergon S.A. | 148 |
20 |
Allergan, Inc. | 2445 |
18 |
University of Utah Research Foundation | 1774 |
18 |
Novartis AG | 11289 |
16 |
Contipro a.s. | 77 |
15 |
Mayo Foundation for Medical Education and Research | 3102 |
14 |
Aihol Corporation | 28 |
14 |
Buck Institute for Research on Aging | 126 |
14 |
MERZ PHARMA GmbH & CO. KGaA | 611 |
14 |
Teoxane | 42 |
14 |
Unity Biotechnology, Inc. | 77 |
14 |
U.S. Nutraceuticals, L.L.C., DBA Valensa International | 27 |
13 |
Sofar Swiss SA | 44 |
13 |
The Johns Hopkins University | 5524 |
12 |
Laboratoires Vivacy | 67 |
12 |
Galderma Holding S.A. | 695 |
12 |
Other owners | 1641 |